Page last updated: 2024-10-27

gabexate and Osteomyelitis

gabexate has been researched along with Osteomyelitis in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.

Research Excerpts

ExcerptRelevanceReference
"Pyogenic osteomyelitis is often accompanied by diabetes, but the disease in the clavicula has rarely been reported."1.30Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus. ( Kasamatsu, Y; Kondo, M; Nagata, H; Nakamura, Y; Yokoo, S; Yoshida, T; Yoshioka, K, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshioka, K1
Nagata, H1
Nakamura, Y1
Kasamatsu, Y1
Yokoo, S1
Yoshida, T1
Kondo, M1

Other Studies

1 other study available for gabexate and Osteomyelitis

ArticleYear
Pyogenic clavicular osteomyelitis associated with disseminated intravascular coagulation and acute renal failure in a patient with non-insulin-dependent diabetes mellitus.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:11

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Clavicle; Diabetes Mellitus, Type 2; Dis

1997